Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

NCT03802526 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: NVP-1805-R1
DRUG: NVP-1805-R2
DRUG: NVP-1805-R1 and NVP-1805-R2

Sponsor

NVP Healthcare